Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Kullberg BJ, Viscoli C, Pappas PG, Vazquez J, Ostrosky-Zeichner L, Rotstein C, Sobel JD, Herbrecht R, Rahav G, Jaruratanasirikul S, Chetchotisakd P, Van Wijngaerden E, De Waele J, Lademacher C, Engelhardt M, Kovanda L, Croos-Dabrera R, Fredericks C, Thompson GR. Kullberg BJ, et al. Clin Infect Dis. 2019 May 30;68(12):1981-1989. doi: 10.1093/cid/ciy827. Clin Infect Dis. 2019. PMID: 30289478 Clinical Trial.
Voriconazole salvage treatment of invasive candidiasis.
Ostrosky-Zeichner L, Oude Lashof AM, Kullberg BJ, Rex JH. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):651-5. doi: 10.1007/s10096-003-1014-3. Epub 2003 Oct 17. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14564539
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. doi: 10.1007/s10096-005-0024-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16261306 Clinical Trial.
Invasive candidiasis in the intensive care unit.
Ostrosky-Zeichner L, Pappas PG. Ostrosky-Zeichner L, et al. Crit Care Med. 2006 Mar;34(3):857-63. doi: 10.1097/01.CCM.0000201897.78123.44. Crit Care Med. 2006. PMID: 16505666 Review.
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting.
Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2007 Apr;26(4):271-6. doi: 10.1007/s10096-007-0270-z. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17333081
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group. Kuse ER, et al. Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9. Lancet. 2007. PMID: 17482982 Clinical Trial.
209 results